PERRIGO COMPANY PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.71 USD | -1.00% |
|
-6.34% | -4.57% |
| May. 07 | Perrigo's Q1 Adjusted Earnings, Net Sales Drop | MT |
| May. 07 | Transcript : Perrigo Company plc, Q1 2024 Earnings Call, May 07, 2024 |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 4.62B | Sales 2025 * | 4.83B | Capitalization | 4.19B |
|---|---|---|---|---|---|
| Net income 2024 * | -74M | Net income 2025 * | 106M | EV / Sales 2024 * | 1.6 x |
| Net Debt 2024 * | 3.21B | Net Debt 2025 * | 3.01B | EV / Sales 2025 * | 1.49 x |
| P/E ratio 2024 * |
-21.2
x | P/E ratio 2025 * |
192
x | Employees | 9,140 |
| Yield 2024 * |
3.59% | Yield 2025 * |
3.82% | Free-Float | 99.69% |
More Fundamentals
* Assessed data
More news
Latest transcript on Perrigo Company plc
More recommendations
More press releases
More news
| 1 day | -1.00% | ||
| 1 week | -6.34% | ||
| Current month | -5.97% | ||
| 1 month | +1.29% | ||
| 3 months | -5.22% | ||
| 6 months | +8.13% | ||
| Current year | -4.57% |
1 week
30.08
33.35
1 month
29.7933.46
Current year
25.7734.60
1 year
25.7740.28
3 years
25.7750.90
5 years
25.7763.86
10 years
25.77215.73
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 23-06-29 | |
Eduardo Bezerra
DFI | Director of Finance/CFO | 49 | 22-05-15 |
Alison Ives
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Orlando Ashford
CHM | Chairman | 55 | 20-12-14 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 17-02-05 |
Bradley Alford
BRD | Director/Board Member | 67 | 17-02-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 18.63% | 13 M€ | -.--% | ||
| 15.31% | 0 M€ | +12.39% | - | |
| 0.66% | 8 M€ | +5.48% | - | |
| 0.46% | 0 M€ | +9.27% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 30.71 | -1.00% | 782,730 |
| 24-05-09 | 31.02 | -0.29% | 1,093,712 |
| 24-05-08 | 31.11 | +3.18% | 1,711,065 |
| 24-05-07 | 30.15 | -9.81% | 3,898,066 |
| 24-05-06 | 33.43 | +1.95% | 1,730,332 |
Delayed Quote Nyse, May 10, 2024 at 04:00 pm EDT
More quotes
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
Sector
Pharmaceuticals
Calendar
2024-05-30
- Ex-dividend day
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
30.71
USD
Average target price
39.5
USD
Spread / Average Target
+28.62%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.57% | 4.19B | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- PRGO Stock